CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells
MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation, proliferation, and apoptosis. Mir-146a is thought to be involved in the regulation of the innate immune response, and its expression is increased in tiss...
Saved in:
Published in | The FASEB journal Vol. 24; no. 7; pp. 2292 - 2300 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The Federation of American Societies for Experimental Biology
01.07.2010
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation, proliferation, and apoptosis. Mir-146a is thought to be involved in the regulation of the innate immune response, and its expression is increased in tissues associated with chronic inflammation. Among the predicted gene targets for mir-146a, the chemokine CCL8/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication. In the present study, we have analyzed changes in the expression of mir-146a in primary human fetal microglial cells upon infection with HIV-1 and found increased expression of mir-146a. We further show that CCL8/MCP-2 is a target for mir-146a in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of MCP-2 chemokine. The clinical relevance of our findings was evaluated in HIV-encephalitis (HIVE) brain samples in which decreased levels of MCP-2 and increased levels of mir-146a were observed, suggesting a role for mir-146a in the maintenance of HIV-mediated chronic inflammation of the brain.--Rom, S., Rom, I., Passiatore, G., Pacifici, M., Radhakrishnan, S., Del Valle, L., Piña-Oviedo, S., Khalili, K., Eletto, D., Peruzzi, F. CCL8/MCP-2 is a target for mir-146a in HIV-1 infected human microglial cells. |
---|---|
AbstractList | MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation, proliferation, and apoptosis. Mir-146a is thought to be involved in the regulation of the innate immune response, and its expression is increased in tissues associated with chronic inflammation. Among the predicted gene targets for mir-146a, the chemokine CCL8/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication. In the present study, we have analyzed changes in the expression of mir-146a in primary human fetal microglial cells upon infection with HIV-1 and found increased expression of mir-146a. We further show that CCL8/MCP-2 is a target for mir-146a in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of MCP-2 chemokine. The clinical relevance of our findings was evaluated in HIV-encephalitis (HIVE) brain samples in which decreased levels of MCP-2 and increased levels of mir-146a were observed, suggesting a role for mir-146a in the maintenance of HIV-mediated chronic inflammation of the brain.--Rom, S., Rom, I., Passiatore, G., Pacifici, M., Radhakrishnan, S., Del Valle, L., Piña-Oviedo, S., Khalili, K., Eletto, D., Peruzzi, F. CCL8/MCP-2 is a target for mir-146a in HIV-1 infected human microglial cells. MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation, proliferation, and apoptosis. Mir-146a is thought to be involved in the regulation of the innate immune response, and its expression is increased in tissues associated with chronic inflammation. Among the predicted gene targets for mir-146a, the chemokine CCL8/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication. In the present study, we have analyzed changes in the expression of mir-146a in primary human fetal microglial cells upon infection with HIV-1 and found increased expression of mir-146a. We further show that CCL8/MCP-2 is a target for mir-146a in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of MCP-2 chemokine. The clinical relevance of our findings was evaluated in HIV-encephalitis (HIVE) brain samples in which decreased levels of MCP-2 and increased levels of mir-146a were observed, suggesting a role for mir-146a in the maintenance of HIV-mediated chronic inflammation of the brain. |
Author | Piña-Oviedo, Sergio Peruzzi, Francesca Passiatore, Giovanni Del Valle, Luis Khalili, Kamel Pacifici, Marco Radhakrishnan, Sujatha Rom, Slava Rom, Inna Eletto, Davide |
Author_xml | – sequence: 1 fullname: Rom, Slava – sequence: 2 fullname: Rom, Inna – sequence: 3 fullname: Passiatore, Giovanni – sequence: 4 fullname: Pacifici, Marco – sequence: 5 fullname: Radhakrishnan, Sujatha – sequence: 6 fullname: Del Valle, Luis – sequence: 7 fullname: Piña-Oviedo, Sergio – sequence: 8 fullname: Khalili, Kamel – sequence: 9 fullname: Eletto, Davide – sequence: 10 fullname: Peruzzi, Francesca |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20181935$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j81KAzEYRYNU7I_uXGteIO2XZPJNspTB2sKIgtbtkKZJTZmfkmkXvr0D1dXlcg8H7pSM2q71hNxzmHMwuAiHORjGM6lAXpEJVxIYaoQRmYA2giFKPSbTvj8AAAeON2QsgGtupJqQsihKvXgt3pmgsaeWnmza-xMNXaJNTIMXLY0tXa2_GGexDd6d_I5-nxvbDoBL3b6OtqbO13V_S66DrXt_95czslk-fxYrVr69rIunkrlMoWQOMxeCzbULYpdL3GZGSeUlV97k2VBR5Sj8FjznToOW1nDjpYDg0TktxYw8XLzH87bxu-qYYmPTT_V_awAeL0CwXWX3KfbV5mNY5QCg4CDFL_IpVZk |
CitedBy_id | crossref_primary_10_1186_s13024_018_0285_1 crossref_primary_10_1186_s12974_023_02856_0 crossref_primary_10_12688_wellcomeopenres_14188_1 crossref_primary_10_17816_RCF192145_174 crossref_primary_10_1038_s41598_020_67460_1 crossref_primary_10_1016_j_brainresbull_2018_03_007 crossref_primary_10_4161_epi_5_7_12762 crossref_primary_10_1007_s11064_013_1209_7 crossref_primary_10_1186_1471_2156_13_72 crossref_primary_10_3390_genes15050574 crossref_primary_10_1155_2013_186872 crossref_primary_10_1186_s12865_017_0237_5 crossref_primary_10_3390_vaccines11020264 crossref_primary_10_1016_j_molmed_2011_06_009 crossref_primary_10_1186_s12974_022_02627_3 crossref_primary_10_2200_S01171ED1V01Y202202BME062 crossref_primary_10_1097_QAD_0b013e32834b95bf crossref_primary_10_1007_s00705_017_3226_3 crossref_primary_10_3389_fnmol_2020_00090 crossref_primary_10_1099_jgv_0_001065 crossref_primary_10_1002_jcp_24254 crossref_primary_10_3390_cells12222591 crossref_primary_10_3389_fimmu_2022_959729 crossref_primary_10_1007_s12035_013_8400_3 crossref_primary_10_3390_pathogens10081018 crossref_primary_10_1002_iub_2296 crossref_primary_10_1074_jbc_M115_675751 crossref_primary_10_3390_v10010013 crossref_primary_10_1111_j_1574_695X_2011_00894_x crossref_primary_10_5301_jbm_5000194 crossref_primary_10_1002_iub_2222 crossref_primary_10_1007_s11481_019_09892_9 crossref_primary_10_1007_s13311_013_0207_4 crossref_primary_10_1016_j_neuro_2012_02_013 crossref_primary_10_1007_s13365_011_0046_1 crossref_primary_10_1002_ijc_28141 crossref_primary_10_1038_s41435_018_0036_x crossref_primary_10_1016_j_virol_2015_01_016 crossref_primary_10_1080_15287394_2011_618973 crossref_primary_10_1007_s11481_018_9779_4 crossref_primary_10_1016_j_biopha_2018_12_121 crossref_primary_10_1016_j_biopha_2017_09_138 crossref_primary_10_1016_j_jinf_2013_05_003 crossref_primary_10_1111_hiv_12822 crossref_primary_10_1016_j_bbrc_2011_05_153 crossref_primary_10_1016_j_jns_2020_117202 crossref_primary_10_3390_cells11040658 crossref_primary_10_1371_journal_pone_0081438 crossref_primary_10_1159_000533595 crossref_primary_10_1016_j_ejphar_2015_03_018 crossref_primary_10_1002_jcp_25131 crossref_primary_10_3390_ijms241612767 crossref_primary_10_1042_AN20130050 crossref_primary_10_1007_s13365_020_00834_3 crossref_primary_10_1016_j_pharep_2017_01_021 crossref_primary_10_1038_jcbfm_2015_154 crossref_primary_10_1002_glia_22363 crossref_primary_10_1002_mc_21937 crossref_primary_10_1089_aid_2017_0217 crossref_primary_10_1016_j_bbamcr_2011_06_012 crossref_primary_10_1182_blood_2012_08_452425 crossref_primary_10_1007_s00401_017_1803_x crossref_primary_10_1016_j_genrep_2020_100956 crossref_primary_10_1007_s13277_013_0927_4 crossref_primary_10_1096_fj_13_232678 crossref_primary_10_1097_COH_0b013e3283497203 crossref_primary_10_1186_1756_8722_5_13 crossref_primary_10_3390_genes4010046 crossref_primary_10_1074_jbc_M114_633081 crossref_primary_10_1097_QAD_0b013e328352adca crossref_primary_10_1016_j_canlet_2011_10_031 crossref_primary_10_1016_j_pneurobio_2016_01_005 crossref_primary_10_1371_journal_pone_0079926 crossref_primary_10_3389_fimmu_2020_00136 crossref_primary_10_3389_fncel_2021_785433 crossref_primary_10_1016_j_pneurobio_2015_05_003 crossref_primary_10_1038_s41598_019_55100_2 crossref_primary_10_1007_s11596_015_1414_5 crossref_primary_10_1177_1759091420981182 crossref_primary_10_1016_j_ijbiomac_2021_11_061 crossref_primary_10_3389_fmicb_2015_00967 crossref_primary_10_1016_j_brainresbull_2017_10_009 crossref_primary_10_1099_vir_0_041186_0 crossref_primary_10_1016_j_cyto_2013_01_020 crossref_primary_10_1155_2013_451248 crossref_primary_10_1093_brain_awv066 crossref_primary_10_1111_imr_12077 crossref_primary_10_1186_s43042_022_00232_w crossref_primary_10_1186_s12974_015_0249_0 crossref_primary_10_1016_j_omto_2023_09_001 crossref_primary_10_1016_j_biopha_2018_12_103 |
ContentType | Journal Article |
DBID | FBQ CGR CUY CVF ECM EIF NPM |
DOI | 10.1096/fj.09-143503 |
DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1530-6860 |
EndPage | 2300 |
ExternalDocumentID | 20181935 US201301862103 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NINDS NIH HHS grantid: P01 NS030916 – fundername: NINDS NIH HHS grantid: P01 NS30916 – fundername: NIMH NIH HHS grantid: MH071162 – fundername: NIMH NIH HHS grantid: R01 MH079751 – fundername: NIMH NIH HHS grantid: R01 MH071162 – fundername: NIMH NIH HHS grantid: MH079751 |
GroupedDBID | --- -DZ -~X .55 0R~ 0VX 123 18M 1OB 1OC 29H 2WC 33P 34G 39C 3O- 4.4 53G 5GY 5RE 85S AAHHS AANLZ ABCUV ABDNZ ABEFU ABJNI ABOCM ABPTK ACCFJ ACCZN ACGFS ACIWK ACNCT ACPOU ACPRK ACXQS ACYGS ADKYN ADZMN AEEZP AEIGN AENEX AEQDE AEQTP AEUYR AFDAS AFFNX AFFPM AFMIJ AFRAH AGCDD AI. AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB BFHJK C1A CS3 DCZOG DU5 D~5 E3Z EBS EJD F20 F5P F9R FBQ FRP HZ~ H~9 J5H L7B LATKE LEEKS MEWTI MVM NEJ O9- OHT OVD Q-A RHF RHI RJQFR ROL SAMSI SJN SUPJJ TEORI TFA TR2 TWZ VH1 W8F WH7 WHG WOQ WXSBR X7M XJT XOL XSW Y6R YBU YCJ YHG YKV YNH YSK Z0Y ZA5 ZCA ZE2 ZGI ZXP ~KM AHBTC AITYG AIZAD BIYOS CGR CUY CVF ECM EIF H13 HGLYW NPM |
ID | FETCH-LOGICAL-c4563-c64cffa78cf2d736b49535e315e9746b465762eb0e11c8083a919e320fe6cc832 |
ISSN | 0892-6638 |
IngestDate | Tue Aug 27 13:56:17 EDT 2024 Wed Dec 27 18:55:12 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4563-c64cffa78cf2d736b49535e315e9746b465762eb0e11c8083a919e320fe6cc832 |
OpenAccessLink | https://europepmc.org/articles/pmc2887261 |
PMID | 20181935 |
PageCount | 9 |
ParticipantIDs | pubmed_primary_20181935 fao_agris_US201301862103 |
PublicationCentury | 2000 |
PublicationDate | July 2010 |
PublicationDateYYYYMMDD | 2010-07-01 |
PublicationDate_xml | – month: 07 year: 2010 text: July 2010 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The FASEB journal |
PublicationTitleAlternate | FASEB J |
PublicationYear | 2010 |
Publisher | The Federation of American Societies for Experimental Biology |
Publisher_xml | – name: The Federation of American Societies for Experimental Biology |
References | 17942673 - Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17016-21 18599350 - Trends Immunol. 2008 Aug;29(8):357-65 16885212 - Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6 17060477 - J Exp Med. 2006 Oct 30;203(11):2519-27 8843093 - Neuroscience. 1996 Sep;74(1):283-92 17468766 - Nat Med. 2007 May;13(5):613-8 11115360 - Exp Mol Pathol. 2000 Dec;69(3):192-201 9468473 - J Biol Chem. 1998 Feb 20;273(8):4289-92 17162663 - J Neurovirol. 2006 Dec;12(6):472-91 10828541 - Neuroscience. 2000;97(3):591-600 16099643 - Curr Opin Genet Dev. 2005 Oct;15(5):563-8 17060945 - Nat Rev Cancer. 2006 Nov;6(11):857-66 11930329 - J Infect Dis. 2002 Apr 15;185(8):1174-8 17113784 - Semin Cancer Biol. 2007 Feb;17(1):65-73 8658171 - Science. 1996 Jun 28;272(5270):1955-8 11574916 - J Infect Dis. 2001 Oct 15;184(8):1015-21 17463290 - Science. 2007 Apr 27;316(5824):608-11 10550927 - Chem Immunol. 1999;72:7-29 17011485 - Dev Cell. 2006 Oct;11(4):441-50 15954144 - J Neurosci Res. 2005 Aug 1;81(3):436-46 8649512 - Nature. 1996 Jun 20;381(6584):667-73 14744438 - Cell. 2004 Jan 23;116(2):281-97 16236258 - Biochem Biophys Res Commun. 2005 Dec 2;337(4):1214-8 17923094 - Cell. 2007 Oct 5;131(1):146-59 18347435 - RNA Biol. 2007 Nov;4(3):131-7 17242365 - Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9 12941428 - Curr Opin Chem Biol. 2003 Aug;7(4):516-23 17622355 - PLoS One. 2007;2(7):e610 18291670 - Semin Cancer Biol. 2008 Apr;18(2):131-40 18381601 - J Cell Physiol. 2008 Sep;216(3):764-70 8558070 - J Leukoc Biol. 1996 Jan;59(1):67-74 18057241 - J Virol. 2008 Feb;82(4):1946-58 9115216 - J Biol Chem. 1997 May 2;272(18):11682-5 19021527 - Biochem Soc Trans. 2008 Dec;36(Pt 6):1211-5 1613466 - J Exp Med. 1992 Jul 1;176(1):59-65 15211354 - Nat Rev Genet. 2004 Jul;5(7):522-31 9655469 - J Neuroimmunol. 1998 Jun 1;86(1):20-9 11100124 - Nat Med. 2000 Dec;6(12):1380-7 19135886 - Cell. 2009 Jan 9;136(1):26-36 15944708 - Nature. 2005 Jun 9;435(7043):834-8 16146764 - Front Biosci. 2006;11:718-32 17463289 - Science. 2007 Apr 27;316(5824):604-8 19596990 - J Immunol. 2009 Aug 1;183(3):2150-8 8745241 - Neuropathol Appl Neurobiol. 1995 Dec;21(6):518-28 16061966 - Methods Mol Biol. 2005;304:49-70 17849003 - PLoS One. 2007;2(9):e873 15459663 - Nat Rev Mol Cell Biol. 2004 Oct;5(10):827-35 17712037 - Physiol Genomics. 2007 Nov 14;31(3):367-73 18801740 - J Biol Chem. 2008 Nov 14;283(46):31315-22 16009126 - Cell. 2005 Jul 15;122(1):6-7 15614608 - J Mol Histol. 2004 Aug;35(6):545-53 2322286 - Biochem Biophys Res Commun. 1990 Mar 30;167(3):904-9 |
References_xml | |
SSID | ssj0001016 |
Score | 2.3922906 |
Snippet | MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation,... |
SourceID | pubmed fao |
SourceType | Index Database Publisher |
StartPage | 2292 |
SubjectTerms | Cells, Cultured Chemokine CCL8 - antagonists & inhibitors Encephalitis, Viral - pathology Gene Expression Regulation - immunology HIV Infections - etiology HIV Infections - genetics HIV Infections - immunology HIV-1 - pathogenicity Humans Inflammation - virology Microglia - virology MicroRNAs - genetics |
Title | CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20181935 |
Volume | 24 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swELdW0KS9ID7GYHzID3tDhiRO7PgRKkqZAIFKJ94qx3WqIJqiUSGxv353dkJDGdPYS5T4lMjy_XK-O98HId9yY2Iuk4Tx1GoWJ4lkilvF5DCOAxNZkQnMdz6_EN1-_P0muZm5sl12yTTbN7_-mFfyP1yFMeArZsm-g7PPH4UBuAf-whU4DNd_4nG7fYbB9eftSxZhZ3K95wO7XezguPjJQEBp9Gh0T3-AEecDr0DD9I35xhiLN7pDlzm67x-aeiqip3PYOz7aa07EHcw4APXu9KOeGzsty-ehS9DJC7Tnnb_0BCNey7KYUV0kYFElC5lJ0_eAx-ay9j3YWl6C9Zn6lgC1QPVJ0RVwZFM6Rr7v3SuxDXYUrvXtPvZmAAXOlT2YNjh4P3YsjLC8mPL1Tf5OnSuiXZNapCVTFIcX6NSpNmx0YFQ5ETCRg-Y0sFZ09SooH7mezFkfTgu5XiZLlflADz0WVsgHW66Sj76h6NMaOUNEHDg80OKBaurxQAEPtMYDLUr6Eg_U4YHO8EAdHj6Tfuf4ut1lVb8MZkAN5syI2OS5lqnJo6HkIsPY4cTyMLFgNcKjAOMysllgw9CkoHtrFSrLoyC3whgQ7etkoZyUdoNQNUwFD20MZBErI7XQWgcqkypPYZMwm2QDFmOgR7ATDfq9CM-_QzCOw4Bvki9-hQb3vl7KoF7Br29StsinGby2yWIOP6jdAW1vmu2SVufoatdx7DfkU0re |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CCL8%2FMCP-2+is+a+target+for+mir-146a+in+HIV-1-infected+human+microglial+cells&rft.jtitle=The+FASEB+journal&rft.au=Rom%2C+Slava&rft.au=Rom%2C+Inna&rft.au=Passiatore%2C+Giovanni&rft.au=Pacifici%2C+Marco&rft.date=2010-07-01&rft.eissn=1530-6860&rft.volume=24&rft.issue=7&rft.spage=2292&rft_id=info:doi/10.1096%2Ffj.09-143503&rft_id=info%3Apmid%2F20181935&rft_id=info%3Apmid%2F20181935&rft.externalDocID=20181935 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0892-6638&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0892-6638&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0892-6638&client=summon |